Why the study?
Does plasma adiponectin concentration correlate with left ventricular mass index and intima-media thickness in adult kidney transplant patients?
Does plasma adiponectin concentration correlate with left ventricular mass index and intima-media thickness in adult kidney transplant patients?
This study found no significant correlation between plasma adiponectin concentration and markers of left ventricular hypertrophy or atherosclerosis (IMT) in kidney transplant patients.
Null finding does not support adiponectin measurement for LVH or atherosclerosis risk assessment; leaves open its role in kidney transplant recipients.
BACKGROUND: Low plasma adiponectin concentration is associated with more frequent occurrence of left ventricular hypertrophy (LVH) and more exaggerated intima-media thickness of common carotid artery (IMT). IMT is an early surrogate marker of atherosclerosis. This study aimed to assess the relationship between plasma adiponectin concentration and left ventricular mass index (LVMI) and IMT in kidney transplant patients (KTP). METHODS: In 88 adult KTP, plasma adiponectin concentration, LVMI, and IMT were estimated. LVH was defined as LVMI >110 or >125 g/m(2) for females and males, respectively. Data presented are means and 95% CI. RESULTS: Plasma adiponectin concentration was similar in KTP with (n = 42) or without LVH (n = 46) (13.5 [11.4-15.6] vs. 13.1 [11.6-14.6] μg/mL, respectively), as well as in KTP subgroups divided according to the IMT value tertiles (p = 0.42) (11.7 [10.0-13.3], 14.2 [11.7-16.6], and 14.0 [11.7-16.4] μg/mL in the lowest, middle, and highest tertiles, respectively). Plasma glucose concentrations were similar in KTPs with LVH or without LVH. No significant correlation was found between plasma adiponectin concentration and both LVMI (R = -0.02; p = 0.87) and IMT (R = 0.09; p = 0.38), respectively. CONCLUSION: Results of this cross-sectional study do not confirm the roles of low adiponectin and high glucose in the pathogenesis of LVH and atherosclerosis in KTP.
No takes yet. Share an insight, caveat, or question.
Adamczak et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: